Abstract
Hypoxic hepatitis (HH), also known as ischemic hepatitis or shock liver, is an acute liver injury caused by liver ischemia. Common underlying conditions that lead to hypoxic hepatitis are cardiac failure, respiratory failure and septic shock. The most significant distinguishing features are a massive, rapid but transient elevation of serum aspartate transaminase (AST) and alanine transaminase (ALT), and the reversal of the original AST/ALT ratio during the declining phase of enzyme changes. Around 50% of patients with HH do not have a documented hypotensive event or shock state and therefore, “shock liver” is not a proper term for these patients. In patients with toxic/septic shock, the oxygen supply to the liver is not decreased, but rather the increased oxygen requirement unbalances the oxygen supply/demand relationship. Thus, the septic liver is not truly “ischemic”. Accordingly, the term “ischemic hepatitis” is not strictly correct either. Hypoxic hepatitis is now the universally preferred term. The incidence of hypoxic hepatitis is 0.2% of total hospital admissions and 1.5–11% in patients in intensive care units. The pathophysiology is multifactorial and includes hepatic congestion due to right heart failure (backward failure) along with decreased hepatic perfusion (forward failure); hypoxemia due to respiratory diseases, reduced oxygen uptake by hepatocytes, and reperfusion injury. The diagnostic criteria include: a compatible clinical setting, such as cardiac, circulatory or respiratory failure; abrupt, significant, but transient rise in serum aminotransferase levels; and exclusion of other causes of hepatocellular necrosis. The therapeutic strategies are mostly supportive including correcting the underlying disease state, avoiding potential complications such as hypoglycemia, hyperglycemia, hyperammonemia and hepatopulmonary syndrome. The mortality rate is more than 50%. High aminotransferases, LDH, PT-INR, arterial ammonia and jaundice are predictors for poor outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tricot R, Benhamou JP, Guillemot R. Urbanczyk a: [hemodynamics of the cardiac liver]. Pathol Biol. 1962;10:1361–4.
Mirouze D, Michel H. The liver in heart failure (author’s transl). Gastroenterol Clin Biol. 1982;6(2):143–7.
Lee SS. ‘Foie cardiaque’: a new name for an old syndrome? Liver Int. 2008;28(6):755–6.
Mallory FB. Necroses of the liver. J Med Res. 1901;6(1):264–80.
Bynum TE, Boitnott JK, Maddrey WC. Ischemic hepatitis. Dig Dis Sci. 1979;24(2):129–35.
Myers RP, Cerini R, Sayegh R, Moreau R, Degott C, Lebrec D, Lee SS. Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology. 2003;37(2):393–400.
Lightsey JM, Rockey DC. Current concepts in ischemic hepatitis. Curr Opin Gastroenterol. 2017;33(3):158–63.
Hilscher MSW. Congestive hepatopathy. Clin Liver Dis. 2016;8(1):68–71.
Van den Broecke A, Van Coile L, Decruyenaere A, Colpaert K, Benoit D, Van Vlierberghe H, Decruyenaere J. Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis. Ann Intensive Care. 2018;8(1):15.
Ciobanu AO, Gherasim L. Ischemic hepatitis – Intercorrelated pathology. Maedica (Buchar). 2018;13(1):5–11.
Jung C, Fuernau G, Eitel I, Desch S, Schuler G, Kelm M, Adams V, Thiele H. Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock. Clin Res Cardiol. 2017;106(5):341–9.
Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore). 2003;82(6):392–406.
Kamiyama T, Miyakawa H, Tajiri K, Marumo F, Sato C. Ischemic hepatitis in cirrhosis. Clinical features and prognostic implications. J Clin Gastroenterol. 1996;22(2):126–30.
Henrion J, Schapira M, Heller FR. Ischemic hepatitis: the need for precise criteria. J Clin Gastroenterol. 1996;23(4):305.
Henrion J. Hypoxic hepatitis. Liver Int. 2012;32(7):1039–52.
Tapper EB, Sengupta N, Bonder A. The incidence and outcomes of ischemic hepatitis: a systematic review with meta-analysis. Am J Med. 2015;128(12):1314–21.
Aboelsoud MM, Javaid AI, Al-Qadi MO, Lewis JH. Hypoxic hepatitis – its biochemical profile, causes and risk factors of mortality in critically-ill patients: a cohort study of 565 patients. J Crit Care. 2017;41:9–15.
Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Schoniger-Hekele M, Madl C, et al. Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med. 2011;37(8):1302–10.
Drolz A, Saxa R, Scherzer T, Fuhrmann V. Extracorporeal artificial liver support in hypoxic liver injury. Liver Int. 2011;31(Suppl 3):19–23.
Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol. 2010;16(48):6046–57.
Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev. 2009;89(4):1269–339.
Vernon H, Kasi A. Anatomy, abdomen, liver. Treasure Island, FL: StatPearls; 2018.
Waseem N, Chen PH. Hypoxic hepatitis: a review and clinical update. J Clin Transl Hepatol. 2016;4(3):263–8.
Lautt WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Phys. 1985;249(5 Pt 1):G549–56.
Seeto RK, Fenn B, Rockey DC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med. 2000;109(2):109–13.
Krejci V, Hiltebrand LB, Sigurdsson GH. Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis. Crit Care Med. 2006;34(5):1456–63.
Aninat C, Seguin P, Descheemaeker PN, Morel F, Malledant Y, Guillouzo A. Catecholamines induce an inflammatory response in human hepatocytes. Crit Care Med. 2008;36(3):848–54.
Edwards JD. Oxygen transport in cardiogenic and septic shock. Crit Care Med. 1991;19(5):658–63.
Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med. 2007;35(6):1599–608.
Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology. 1995;21(5):1238–47.
Moreau R, Lee SS, Soupison T, Roche-Sicot J, Sicot C. Abnormal tissue oxygenation in patients with cirrhosis and liver failure. J Hepatol. 1988;7(1):98–105.
Chang PE, Goh BG, Ekstrom V, Ong ML, Tan CK. Low serum albumin predicts early mortality in patients with severe hypoxic hepatitis. World J Hepatol. 2017;9(22):959–66.
Taylor RM, Tujios S, Jinjuvadia K, Davern T, Shaikh OS, Han S, Chung RT, Lee WM, Fontana RJ. Short and long-term outcomes in patients with acute liver failure due to ischemic hepatitis. Dig Dis Sci. 2012;57(3):777–85.
Mohacsi P, Meier B. Hypoxic hepatitis in patients with cardiac failure. J Hepatol. 1994;21(5):693–5.
Henrion J, Descamps O, Luwaert R, Schapira M, Parfonry A, Heller F. Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow. J Hepatol. 1994;21(5):696–703.
Fuhrmann V, Jager B, Zubkova A, Drolz A. Hypoxic hepatitis – epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr. 2010;122(5–6):129–39.
Henrion J, Minette P, Colin L, Schapira M, Delannoy A, Heller FR. Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 consecutive cases. Hepatology. 1999;29(2):427–33.
Ucgun I, Ozakyol A, Metintas M, Moral H, Orman A, Bal C, Yildirim H. Relationship between hypoxic hepatitis and cor pulmonale in patients treated in the respiratory ICU. Int J Clin Pract. 2005;59(11):1295–300.
Mathurin P, Durand F, Ganne N, Mollo JL, Lebrec D, Degott C, Erlinger S, Benhamou JP, Bernuau J. Ischemic hepatitis due to obstructive sleep apnea. Gastroenterology. 1995;109(5):1682–4.
Henrion J, Colin L, Schapira M, Heller FR. Hypoxic hepatitis caused by severe hypoxemia from obstructive sleep apnea. J Clin Gastroenterol. 1997;24(4):245–9.
Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Kitzberger R, Warszawska J, et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med. 2009;35(8):1397–405.
Drolz A, Jager B, Wewalka M, Saxa R, Horvatits T, Roedl K, Perkmann T, Zauner C, Kramer L, Ferenci P, et al. Clinical impact of arterial ammonia levels in ICU patients with different liver diseases. Intensive Care Med. 2013;39(7):1227–37.
Trilok G, Qing YC, Li-Jun X. Hypoxic hepatitis: a challenging diagnosis. Hepatol Int. 2012;6(4):663–9.
Raurich JM, Perez O, Llompart-Pou JA, Ibanez J, Ayestaran I, Perez-Barcena J. Incidence and outcome of ischemic hepatitis complicating septic shock. Hepatol Res. 2009;39(7):700–5.
Gitlin N, Serio KM. Ischemic hepatitis: widening horizons. Am J Gastroenterol. 1992;87(7):831–6.
Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SK. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology. 2009;136(7):2159–68.
Jager B, Drolz A, Michl B, Schellongowski P, Bojic A, Nikfardjam M, Zauner C, Heinz G, Trauner M, Fuhrmann V. Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis. Hepatology. 2012;56(6):2297–304.
Kneidinger N, Funk GC, Lindner G, Drolz A, Schenk P, Fuhrmann V. Unmeasured anions are associated with short-term mortality in patients with hypoxic hepatitis. Wien Klin Wochenschr. 2013;125(15–16):474–80.
Horvatits T, Kneidinger N, Drolz A, Roedl K, Rutter K, Kluge S, Trauner M, Fuhrmann V. Prognostic impact of ICG-PDR in patients with hypoxic hepatitis. Ann Intensive Care. 2015;5(1):47.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Liu, H., Yoon, K.T., Lee, S.S. (2022). Hypoxic Hepatitis. In: Valla, D., Garcia-Pagan, J.C., De Gottardi, A., Rautou, PE. (eds) Vascular Disorders of the Liver . Springer, Cham. https://doi.org/10.1007/978-3-030-82988-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-82988-9_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-82987-2
Online ISBN: 978-3-030-82988-9
eBook Packages: MedicineMedicine (R0)